Prostate Cancer - Results from #1780

Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer. November 14, 2023

National long-term survival estimates after radical prostatectomy for prostate cancer. November 14, 2023

Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study. November 14, 2023

Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression. November 14, 2023

Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation. November 14, 2023

Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors. November 14, 2023

Social Media Interventions for Patients and Public: Opportunities and Challenges for the Urology Community November 13, 2023

Determining clinical perspectives and strategies for improving enrollment of minoritized communities in prostate cancer clinical trials. November 13, 2023

The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer. November 13, 2023

Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer. November 13, 2023

Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN. November 13, 2023

Radiation therapy margin reduction for patients with localized prostate cancer: A prospective study of the dosimetric impact and quality of life. November 13, 2023

A contemporary review of the treatments and challenges associated with penile rehabilitation after radical prostatectomy including a proposed optimal approach. November 10, 2023

Impact of the COVID-19 pandemic on delivery of prostate cancer care in Australia: An interrupted time series analysis. November 10, 2023

A qualitative study on healthcare professional and patient perspectives on nurse-led virtual prostate cancer survivorship care. November 10, 2023

Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer. November 10, 2023

Mapping the contributions of dyadic approaches to couples' psychosocial adaptation to prostate cancer: a scoping review. November 10, 2023

The quality of YouTube videos on radiotherapy and prostatectomy for prostate cancer. November 10, 2023

Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Update. November 10, 2023

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. November 10, 2023

Page 90 of 1435